The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI)

13 Aug 2020 09:28

RNS Number : 0538W
Cenkos Securities PLC
13 August 2020
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cenkos Securities plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Collagen Solutions plc

 

(c) Name of the party to the offer with which exempt principal trader is connected:

Collagen Solutions plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12 August 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ord GBP0.01

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

317,218

0.07

-

-

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

317,218

0.07

-

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ord GBP0.01

Purchases

-

-

-

Ord GBP0.01

Sales

100,000

2.725

2.725

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

13 August 2020

Contact name:

Carla Brayson

Telephone number:

020 7397 8984

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOGPUMPRUPUURW
Date   Source Headline
29th Apr 20208:28 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20204:25 pmRNSForm 8.3 - Collagen Solutions plc
27th Apr 20204:22 pmRNSForm 8 (OPD) - Collagen Solutions plc
27th Apr 20202:58 pmRNSForm 8.3 - Collagen Solutions plc
27th Apr 202011:05 amRNSForm 8.3 - Collagen Solutions plc
24th Apr 20202:51 pmRNSForm 8.3 - Collagen Solutions Plc
24th Apr 20202:45 pmRNSForm 8.3
24th Apr 202012:21 pmRNSForm 8.3 - Collagen Solutions Plc
24th Apr 20209:40 amRNSForm 8.5 (EPT/NON-RI)
24th Apr 20207:00 amRNSDirector/PDMR Shareholding
23rd Apr 202012:10 pmGNWForm 8.3 - Collagen Solutions Plc
23rd Apr 20207:00 amRNSTrading update
22nd Apr 20201:30 pmRNSForm 8.3 - Collagen Solutions plc
22nd Apr 20209:27 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20209:31 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20208:21 amRNSForm 8.5 (EPT/NON-RI)
17th Apr 20202:33 pmRNSForm 8.3 - Collagen Solutions plc
17th Apr 202012:35 pmRNSForm 8.3 - Collagen Solutions plc
17th Apr 20208:35 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20207:00 amRNSStrategic Review and Formal Sale Process
18th Mar 20207:00 amRNSTrading update
3rd Dec 20197:00 amRNSHalf-year Report
19th Nov 20197:00 amRNSInvestor results presentation
13th Nov 20197:00 amRNSDirectorate Change
22nd Oct 20197:00 amRNSTrading Update & Notice of Results
3rd Oct 20197:00 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSInvestor presentation
28th Aug 201911:29 amRNSResult of AGM
28th Aug 20197:00 amRNSAGM Statement
8th Aug 201910:53 amRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSPosting of Annual Report and Notice of AGM
11th Jul 20197:00 amRNSDirector/PDMR Shareholding
9th Jul 201912:18 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSFinal Results
9th Jul 20197:00 amRNSDirectorate Change
13th Jun 20192:22 pmRNSNotice of Results
10th Jun 20195:13 pmRNSHolding(s) in Company
10th Jun 20195:09 pmRNSHolding(s) in Company
7th Jun 20199:38 amRNSHolding(s) in Company
6th Jun 20192:27 pmRNSHolding(s) in Company
6th Jun 201912:35 pmRNSHolding(s) in Company
6th Jun 20199:52 amRNSDirector/PDMR Shareholding
6th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 201911:50 amRNSResult of General Meeting and Open Offer
23rd May 20197:00 amRNSInvestor presentation
20th May 20197:00 amRNSStrategic Investment, Placing and Open Offer
9th Apr 20198:08 amEQSCollagen Solutions's losses narrow on improved top line performance
9th Apr 20197:00 amRNSTrading Update
21st Mar 201911:36 amRNSHolding(s) in Company
21st Feb 20192:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.